OnDemand WTP Pricing Research

Pricing’s Point Man | PharmaExec

Despite its underlying importance to the very survival of the R&D industry, market access has not received the attention it deserves as a living, strategic function, with its own embellished litany of shared learnings and “best practices.” One prominent industry practitioner, Ed Schoonveld, currently a managing principal at ZS Associates, has moved to fill that gap with a new, second edition of his 2012 book, The Price of Global Health. In the following Q&A, Pharm Exec Editor-in-Chief William Looney talks to Schoonveld about the key policy and management issues around market access, and what he sees as a necessary effort to take this relatively new set of pharma capabilities to the next level—from theory to practice.

Read complete article here:

Pricing’s Point Man.

1 Comment on "Pricing’s Point Man | PharmaExec"

Trackback | Comments RSS Feed

Inbound Links

  1. Pricing News Daily > 5/13/15 : Pricing News | 2015/05/14

Post a Comment

WP-SpamFree by Pole Position Marketing